NICOLE BIELECKI: Open Payments
NPI 1619506060 · GREELEY, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,491 in 62 payments from 18 companies in 2025. Trend: 2023 $1,310 · 2024 $1,659 · 2025 $1,491
Food & beverage: $1,135Education: $356
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $238 |
| Novartis Pharmaceuticals Corporation | 11 | $190 |
| Janssen Biotech, Inc. | 5 | $161 |
| E.R. Squibb & Sons, L.L.C. | 4 | $140 |
| UCB, Inc. | 4 | $121 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $107 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $104 |
| Galderma Laboratories, L.P. | 5 | $90 |
| Organon LLC | 5 | $62 |
| ABBVIE INC. | 2 | $48 |
Products named: DUPIXENT, TREMFYA, Sotyktu, Bimzelx, NEMLUVIO, Cabtreo, COSENTYX, CIBINQO.
Industry payments across CO — which companies pay providers there.
